|
Pipeline / Clinical Trials Product Development PipelineRegeneRx has initiated 5 clinical trials to develop 3 product candidates in our pipeline. The product candidates are all Tβ4-based peptides and have been formulated to optimize the clinical potential in various medical indications, all with unmet needs. All clinical studies are dose-escalating, randomized, double-blinded and placebo-controlled.
For full updated detail of each RegeneRx clinical trial go to www.clinicaltrials.gov or click on the highlighted indication above for each trial. |
|||||||||||||||